Medical Board

Stephen E. Sallan, MD
Stephen E. Sallan, MD
PGH Medical Board Chairman

Chief of Staff and Chairman of the Medical Staff Executive Committee at Dana-Farber Cancer Institute since 1995 and Chief of Staff Emeritus in 2012, Dr. Stephen E. Sallan is a renowned pediatric oncologist. Having received both his undergraduate degree and his MD from Wayne State University, Dr. Sallan completed his residencies in pediatrics at the Boston Floating Hospital, the Children's Hospital of Philadelphia and at the Hospital for Sick Children, London. In 1973, he served as a fellow in pediatric oncology at Children’s Hospital at Dana-Farber Cancer Institute, where he joined the staff in 1975.

Board Certified in Pediatrics, he has held various academic appointments at Harvard Medical School where he has been a Professor of Pediatrics since 1988. Dr. Sallan's laboratory and clinical research focuses on the biology and therapy of childhood malignancies, particularly acute lymphoblastic leukemia and pediatric brain tumors. Highly recognized, Dr. Sallan's research has led to the development of pediatric leukemia clinical protocols used worldwide. Dr. Sallan was named the Quick Family Senior Investigator in Pediatric Oncology in 2002 and has received the Distinguished Alumni Award from the Wayne State University School of Medicine and the James Carreras Prize for International Pediatrician of the Year.

Lawrence Nathan Shulman, MD
Lawrence Nathan Shulman, MD

Director of the Center for Global Cancer Medicine, Director of Regional Strategy Development and Chief of Staff since 2012 at Dana-Farber Cancer Institute, Dr. Shulman is actively involved in the development and testing of new therapies for patients with breast cancer. Prior to these positions, Dr. Schulman had served as the institute’s Chief Medical Officer, Senior Vice President for Medical Affairs, and Chief of the Division of General Oncology, Department of Medical Oncology.  Dr. Shulman received his undergraduate degree from Syracuse University where he was Phi Beta Kappa. He received his MD from Harvard Medical School in 1975 and undertook his residency in internal medicine at Beth Israel Hospital in Boston, where he was also a fellow in hematology and oncology.

Board Certified in Internal Medicine, Medical Oncology and in Hematology, Dr. Shulman also previously served as clinical director of hematology-oncology at Brigham and Women’s Hospital and as Dana Farber’s Vice-Chair for Clinical Services in Adult Oncology. He is currently an Associate Professor of Medicine at Harvard Medical School where he was the Harvard-Sandoz Scholar in Medicine from 1990-1993. Dr. Shulman's particular area of interest is breast cancer research. At the national level he is a member of the Cancer and Leukemia Group B Breast Core Committee and the national principal investigator on a North American Breast Intergroup Phase III Adjuvant trial, as well as the Global Principal Investigator on a Phase III vaccine trial for patients with metastatic breast cancer. Dr. Shulman is a member of the American Society of Clinical Oncology’s Quality of Care Committee and of its Electronic Health Record Workgroup. He is a member of the Commission on Cancer of the American College of Surgeons.

Gilbert H. Mudge, MD
Gilbert H. Mudge, MD

Dr. Gilbert H. Mudge Jr is Senior Advisor for Partners International Medical Services and thus oversees the clinical components of all international programs for Partners Healthcare. In addition to these responsibilities, he has busy clinical and teaching commitments. Dr. Mudge received his undergraduate degree at Amherst College and his MD from Columbia University’s College of Physicians and Surgeons. After completing his internship and residency in Internal Medicine at Presbyterian Hospital in New York, Dr. Mudge was a research fellow at both Harvard Medical School and Peter Bent Brigham Hospital. In addition to holding a number of clinical appointments and being an active member of many institutions including the International Society for Heart and Lung Transplantation, American Heart Association and the American College of Cardiology, he is an Associate Professor at Harvard Medical School.

Board Certified in Internal Medicine and Cardiovascular Disease, Dr. Mudge’s clinical specialty lies in advanced heart disease, congestive heart failure and heart transplantation. He was asked to start the first heart transplant program in New England in 1983 and has followed hundreds of such patients to date. Dr. Mudge has been named one of the Best Doctors in Boston by Boston Magazine for five years and has been honored with the Partners in Excellence Award five times.

David J. Sugarbaker, MD
David J. Sugarbaker, MD

Dr. Sugarbaker is Chief and Vice-Chair of Thoracic Surgery at Brigham and Women's Hospital (BWH) and the Richard E. Wilson Professor of Surgical Oncology at Harvard Medical School. He has been actively involved in the development of several programs, including the Brigham Lung Transplant Program, the Thoracic Oncology Program at Dana Farber Cancer Institute/ BWH, the Lung Volume Reduction Program at BWH and the Women's Lung Cancer Program at BWH. Dr. Sugarbaker is also the Founder of the clinical and research International Pleural Mesothelioma Program. A graduate of Wheaton College and Cornell University Medical College (1979), Dr. Sugarbaker completed his surgery residency at Peter Bent Brigham Hospital and his cardiothoracic surgery residency at Toronto General Hospital.

Dr. Sugarbaker is Board Certified in Thoracic Surgery. A world-renowned thoracic surgeon, his interests and area of research are lung cancer, mesothelioma, esophageal cancer and minimally invasive surgery. Dr. Sugarbaker is responsible for the development of the “tri-modal” approach, currently in use, for treating malignant pleural mesothelioma, leading to significant improvements in patient survival rates. Dr. Sugarbaker is a leader in developing new clinical trial opportunities in thoracic as well as non-invasive surgical methods and other beneficial mesothelioma treatment options. Dr. Sugarbaker is also a member and Treasurer of the American Association for Thoracic Surgery and Vice President of the Graham Education and Research Foundation Committee. He has been named one of “America’s Top Doctors” by Castle Connolly annually since 2002, and earned special distinction in 2007 and 2009.